Skip to main content

Comparison of treatment completion rates with three short-course rifamycin-based regimens (three months of daily isoniazid plus rifampicin [3HR], three months of once-weekly isoniazid plus rifapentine [3HP], and four months of daily rifampicin [4R]) for treatment of latent tuberculosis infection in patients with end-stage kidney disease: A randomised controlled clinical trial]

Open
  • Protocol code: PI21/004444
  • EudraCT code: 2021-003995-15
  • Research group: Pneumology
  • Service: Pneumology
  • Principal investigator:  De Souza Galvao, Maria Luiza
  • Pathology: Malalties del sistema respiratori
  • Phase: Fase IV